Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Global Markets Slide as Tech Stocks Sink, Yields Rise, and AI Concerns Deepen 
SpaceX Edges Toward Landmark IPO as Elon Musk Confirms Plans 
Mexico Moves to Increase Tariffs on Asian Imports to Protect Domestic Industries 
Fed Rate Cut Signals Balance Between Inflation and Jobs, Says Mary Daly 
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform 
China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
Japan Business Sentiment Hits Four-Year High, Boosting Expectations of BOJ Rate Hike 
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters 
Asian Currencies Steady as Fed Delivers Hawkish Rate Cut; Aussie and Rupee Under Pressure 
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure 
Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks 
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
Modi and Trump Hold Phone Call as India Seeks Relief From U.S. Tariffs Over Russian Oil Trade 
Nestlé revealed it will close two of its Health Science plants in the United States. The Swiss company explained that this move is a strategy to increase efficiency in its health nutrition business unit.
Nestlé Health Science is the company’s division that is focused on the research, development, and manufacturing of healthy and medical nutrition products. It is mainly known for its Nutren and Meritene brands. At any rate, it is said to be currently in the process of bringing together its supply chain network to boost efficiency.
The company issued a Worker Adjustment and Retraining Notification (WARN), and Nestlé Health Science’s director of project management and HR special projects, Chris Richardson, said in the memo that due to the closure of their two facilities, more than 300 employees are set to lose their jobs.
To be more exact, Richardson stated in the WARN that “312 positions will be eliminated on a permanent basis.” The two plants that would be shut down are those located in Findlay and Robinson Township, and the job cuts are expected to begin in late June.
“There are no bumping rights at the impacted facility. The employees have no elected collective bargaining representative,” the project management director added.
According to Penn Live News, Nestlé Health Sciences filed the WARN notice at the Pennsylvania Department of Industry. It was indicated in the memo that the company’s facilities at 600 Boyce Road, under the name of HVL LLC, and 112 Technology Drive in Pittsburgh, listed under the name Pure Encapsulations are set to cease operations.
The WARN Act is a government regulation that protects employees, communities, and even the families of workers in the U.S. This law provides protection by requiring companies and other employers to notify everyone if they are planning to close business. It is a must for this type of notice to be posted 60 days in advance.
